AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE
EMERYVILLE, Calif., May 19, 2023 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it has signed an exclusive license agreement with British specialty chemicals company Croda International Plc, (“Croda”) for the supply of sustainable squalene. … Read more